Rol' beta-kletok v regulyatsii gomeostaza glyukozyv norme i pri sakharnom diabete 2 tipa
https://doi.org/10.14341/2072-0351-5581
Abstract
About the Author
Alexander Sergeevich AmetovReferences
1. Barg S., Elliason L., Renstrom E. et al. A subject of 50 secretory granules in close contact with a-type Са2+ channels accounts for first-phase insulin secretion in mouse p-sells. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. I, p. 74.
2. Bernard-Kargar C. Endocrine pancreas plasticity under physiological condi tions. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 30.
3. Bonner-Weir S. p-cell turnover: its assessment and implications. Birth, Life and Death of a p-cell in Type 2 Diabetes. Diabetes, 2001, February, V. 50, suppl. 1, 20.
4. Bratanova-Tochkova T. K., Cheng H., Daniel S. et al. Triggering and argumentation mechanisms granule pools and biphasic insulin secretion. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 83.
5. Cerasi E. Type 2 Diabetes: To stimulate or not to stimulate the p-cell. Metabolism Clinical and Experimental, 2000, v. 49, 10, suppl. 2, 1-3.
6. De Fronzo R. Pharmacologic therapy for type 2 diabetes mellitus. Ann. Intern. Med., 1999, 131, 281-303.
7. Del Prato S., Marchetti P. and bonadonna R. C. Phasic insulin release and metabolism regulation in Type 2 Diabetes. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 109.
8. Fajans S. Maturity-onset diabetes of the young (MODY). Diabetes Metab. Rev., 1989, 5, 579-606.
9. Henquin J.-C, Boitard C, Efendic S. et al. Insulin Secretion movement at all levels. Kinetics of insulin release in health and Type 2 Diabetes. Diabetes, 2002, February, V. 51, suppl. 1, p. 1.
10. Hotamisligil G. Mechanisms of TNT-a-inducted insulin resistance. Experiment. And Clinical Endocrine, 1999, 107, 110-125.
11. Kloppel G. et al. Islet pathology and pathogenesis of type 1 and type 2 diabetes revisited. Surv. Synth. Pathol. Res., 1985, 4, 110-125.
12. Lang et al. N. Engl. J. Med. 1979. 301, 1023. LJht. Diabetes Mellitus. Theory and Practice. Third Edition. Max Ellenberg, Harold Rifkin, 1983.
13. Malaisse W. On the track of the beta-cell. Endocrine moiety. Diabetologia, 2001, 4, 44.
14. Olefsky J. Insulin resistance in non-insulin-dependent diabetes mellitus. Current option in Endocrinol. And Diabetes, 1995, 2, 290-299.
15. Polonsky K. Abnormal patterns of insulin secretion in non-insulindependent diabetes mellitus. N. Engl. J. Med., 1988, 318, 1231- 1239.
16. Polonsky K. Alternations in immunoreactive proinsulin and insulin clearance inducted by weight loss in NIDDM. Diabetes, 1994, 43, 871- 877.
17. Reaven G.M. Plasma insulin, C-peptide and proinsulin concentrations inobese and non-obese individuals with varying degrees of glucose intolerance. J. Clin. Endocrinol. and Metabolism, 1993, 76, 44-48.
Review
For citations:
Ametov A.S. Rol' beta-kletok v regulyatsii gomeostaza glyukozyv norme i pri sakharnom diabete 2 tipa. Diabetes mellitus. 2008;11(4):6-11. https://doi.org/10.14341/2072-0351-5581
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
